Follow The Filings

Insider trades

Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.

4,841 companies covered, latest filing Oct 23.

  • $79.2M bought by 61 insiders at 47 companies
  • $239M sold by 49 insiders outside a trading plan
  • $2.5B sold by 203 insiders under 10b5-1 plans
  • 10 companies where two or more insiders bought (30 days)

Biggest buys

Past week, each insider's filings added up.

  1. CRBGCorebridge Financial
    Life Insurance Co Nippon10% owner
    1,430,631 shares at $34.37 Oct 15–21, 5 filings +1.1% to stake 2 superinvestors bought in Q2
    $49.2M
  2. DOLEDole PLC
    Pale Fire Capital SE10% owner, +4 joint filers
    648,356 shares at $13.19 Oct 20–22 +6.7% to stake
    $8.6M
  3. APLDApplied Digital
    Jason Gechen ZhangPresident
    300,000 shares at $18.86 Oct 16 +12% to stake 5 superinvestors bought in Q2
    $5.7M
  4. RENTRent the Runway
    STORY3 Capital Partners, LLCDirector, +3 joint filers
    632,922 shares at $3.55 Oct 21 +15% to stake
    $2.2M
  5. RENTRent the Runway
    CHS US Investments LLC10% owner, +4 joint filers
    458,245 shares at $3.55 Oct 21 +2% to stake
    $1.6M
  6. FBKFB Financial
    Orrin H Ingram IIDirector
    29,081 shares at $52.88 Oct 20 +31% to stake
    $1.5M
  7. TENXTenax Therapeutics
    ADAR1 Capital Management, LLC10% owner, +1 joint filer
    922,849 shares at $1.59 Oct 19–21 +14% to stake
    $1.5M
  8. APLDApplied Digital
    Wes CumminsCEO
    55,803 shares at $18.04 Oct 16 +1% to stake 5 superinvestors bought in Q2
    $1M
  9. RAPPRapport Therapeutics
    Steven M PaulDirector
    35,714 shares at $27.28 Oct 22 +86% to stake
    $974K
  10. SNESSenesTech
    Glenbrook Capital Management10% owner
    1,087,679 shares at $0.7200 Oct 15–22, 2 filings
    $781K

Biggest sales

Past week, each insider's filings added up. Planned sales are marked.

  1. IHTInnSuites Hospitality Trust
    James F WirthCEO
    43,111 shares at $46,654.38 Oct 20 0.5% of stake Planned sale (10b5-1)
    $2B
  2. SNOWSnowflake
    Frank SlootmanDirector
    300,000 shares at $316.43 Oct 19 94% of stake Planned sale (10b5-1)
    $94.9M
  3. TALOTalos Energy
    Empresarial De Capitales S.a. De C.v. Control10% owner
    4,893,590 shares at $17.55 Oct 15–19, 2 filings 17% of stake
    $85.9M
  4. TRVTravelers
    Alan D SchnitzerCEO
    88,900 shares at $396.77 Oct 21 23% of stake
    $35.3M
  5. PATHUiPath
    Daniel DinesCEO
    2,500,000 shares at $13.23 Oct 15–16 7.9% of stake Planned sale (10b5-1)
    $33.1M
  6. UTHRUnited Therapeutics
    Martine A RothblattCEO
    47,500 shares at $555.06 Oct 16–22, 5 filings 13% of stake Planned sale (10b5-1)
    $26.4M
  7. MUMicron Technology
    Scott J DeboerPres. & Chief Tech & Prod Offr
    28,545 shares at $900.00 Oct 16 16% of stake Planned sale (10b5-1)
    $25.7M
  8. ALMRAlamar Biosciences
    Qiming Corporate GP VI, Ltd.10% owner, +6 joint filers
    733,811 shares at $28.64 Oct 15–22, 3 filings 29% of stake
    $21M
  9. SNOWSnowflake
    Benoit DagevilleDirector
    50,000 shares at $321.74 Oct 21 2.1% of stake Planned sale (10b5-1)
    $16.1M
  10. LINDLindblad Expeditions
    Sven-Olof LindbladDirector
    403,674 shares at $35.31 Oct 16–22, 2 filings 3.8% of stake Planned sale (10b5-1)
    $14.3M

Cluster buying

Companies where two or more insiders bought on the open market in the last 30 days, most buyers first

  1. TSMTaiwan Semiconductor 19 insiders, $80K

    Che-Chia Wei CEO, Yuh-Jier Mii COO, Yung-Pei Chin COO, Yung-Chin Hou COO, +15 more

    Latest buy Oct 7 19 executives 20 superinvestors sold in Q2
  2. SPGSimon Property Group 11 insiders, $461K

    Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more

    Latest buy Sep 30
  3. FULH. B. Fuller 9 insiders, $1.1M

    R Jeffrey Bailly Director, Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, +5 more

    Latest buy Oct 16 1 executive 1 superinvestor bought in Q2
  4. RAPPRapport Therapeutics 6 insiders, $1.7M

    Steven M Paul Director, John Maraganore Director, Troy A. Ignelzi CFO, Wendy B. Young Director, +2 more

    Latest buy Oct 23 1 executive
  5. ATCHAtlasClear 5 insiders, $163K

    Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more

    Latest buy Sep 25 3 executives
  6. RGCORGC Resources 5 insiders, $85K

    John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more

    Latest buy Oct 1 3 executives
  7. WVVIWillamette Valley Vineyards 5 insiders, $75K

    Michael Jordan Osborn CEO, John Walter Hazlett CFO, Gregory William Voorhies Director, James W Bernau President, +1 more

    Latest buy Oct 12 3 executives
  8. MPBMid Penn Bancorp 5 insiders, $25K

    Matthew G De Soto Director, Albert J. Evans Director, Joel L. Frank Director, Theodore W Mowery Director, +1 more

    Latest buy Sep 30
  9. DXDynex Capital 4 insiders, $245K

    Smriti Laxman Popenoe CEO, Byron L Boston CEO, Terrence John Connelly Jr. Chief Investment Officer, Michael Andrew Sartori CFO

    Latest buy Oct 20 4 executives
  10. ANIXAnixa Biosciences 4 insiders, $203K

    Lewis H Titterton Jr. Director, Amit Kumar CEO, Michael Catelani CFO, Arnold M Baskies Director

    Latest buy Oct 22 2 executives

BZUN insider trades

Every open-market buy and sale in BZUN, one row per filing, newest first

BZUN page
  1. Wenbin Qiu CEO
    BZUNBaozun
    Buy
    $40K 11,400 shares at $3.50 +0.7% to stake
    Traded Oct 21–22 Filed Oct 23
  2. Wenbin Qiu CEO
    BZUNBaozun
    Buy
    $20K 5,800 shares at $3.44 +0.3% to stake
    Traded Oct 14 Filed Oct 16
  3. Wenbin Qiu CEO
    BZUNBaozun
    Buy
    $40K 11,800 shares at $3.40 +0.7% to stake
    Traded Oct 12–13 Filed Oct 14
  4. Wenbin Qiu CEO
    BZUNBaozun
    Buy
    $40K 13,900 shares at $2.87 +0.8% to stake
    Traded Sep 18–21 Filed Sep 22
  5. Wenbin Qiu CEO
    BZUNBaozun
    Buy
    $40K 14,400 shares at $2.79 +0.9% to stake
    Traded Sep 16–17 Filed Sep 18
  6. Junhua Wu Chief Strategy Officer
    BZUNBaozun
    Buy
    $38K 13,900 shares at $2.73 +5.2% to stake
    Traded Sep 15 Filed Sep 17
  7. Wenbin Qiu CEO
    BZUNBaozun
    Buy
    $40K 14,600 shares at $2.73 +0.9% to stake
    Traded Sep 14–15 Filed Sep 16
  8. Junhua Wu Chief Strategy Officer
    BZUNBaozun
    Buy
    $38K 13,500 shares at $2.85 +5.3% to stake
    Traded Sep 2 Filed Sep 4
  9. Junhua Wu Chief Strategy Officer
    BZUNBaozun
    Buy
    $83K 29,000 shares at $2.85 +13% to stake
    Traded Jun 24 Filed Jun 26
  10. Wenbin Qiu CEO
    BZUNBaozun
    Buy
    $28K 10,000 shares at $2.81 +0.6% to stake
    Traded Jun 22 Filed Jun 24
  11. Wenbin Qiu CEO
    BZUNBaozun
    Buy
    $56K 20,000 shares at $2.80 +1.3% to stake
    Traded Jun 17–18 Filed Jun 22
  12. Junhua Wu Chief Strategy Officer
    BZUNBaozun
    Buy
    $53K 18,500 shares at $2.84 +9% to stake
    Traded Jun 17 Filed Jun 22
  13. Wenbin Qiu CEO
    BZUNBaozun
    Buy
    $55K 20,000 shares at $2.76 +1.3% to stake
    Traded Jun 15–16 Filed Jun 17
  14. Wenbin Qiu CEO
    BZUNBaozun
    Buy
    $54K 20,000 shares at $2.70 +1.3% to stake
    Traded Jun 11–12 Filed Jun 15
  15. Junhua Wu Chief Strategy Officer
    BZUNBaozun
    Buy
    $48K 18,000 shares at $2.69 +9.6% to stake
    Traded Jun 11 Filed Jun 15
  16. Wenbin Qiu CEO
    BZUNBaozun
    Buy
    $54K 20,000 shares at $2.68 +1.3% to stake
    Traded Jun 9–10 Filed Jun 11
  17. Wenbin Qiu CEO
    BZUNBaozun
    Buy
    $54K 20,000 shares at $2.71 +1.3% to stake
    Traded Jun 5–8 Filed Jun 9
  18. Wenbin Qiu CEO
    BZUNBaozun
    Buy
    $53K 20,000 shares at $2.65 +1.3% to stake
    Traded Jun 3–4 Filed Jun 5
  19. Junhua Wu Chief Strategy Officer
    BZUNBaozun
    Buy
    $54K 20,000 shares at $2.70 +12% to stake
    Traded Jun 1 Filed Jun 3
  20. Wenbin Qiu CEO
    BZUNBaozun
    Buy
    $54K 20,000 shares at $2.71 +1.4% to stake
    Traded Jun 1–2 Filed Jun 3
  21. Junhua Wu Chief Strategy Officer
    BZUNBaozun
    Buy
    $50K 19,500 shares at $2.56 +13% to stake
    Traded May 28 Filed Jun 1
  22. Wenbin Qiu CEO
    BZUNBaozun
    Buy
    $51K 20,000 shares at $2.57 +1.4% to stake
    Traded May 28–29 Filed Jun 1
  23. Wenbin Qiu CEO
    BZUNBaozun
    Buy
    $51K 20,000 shares at $2.57 +1.4% to stake
    Traded May 26–27 Filed May 28
  24. Junhua Wu Chief Strategy Officer
    BZUNBaozun
    Buy
    $26K 10,000 shares at $2.55 +7.2% to stake
    Traded May 26 Filed May 28
  25. Wenbin Qiu CEO
    BZUNBaozun
    Buy
    $50K 16,000 shares at $3.14 +1.1% to stake
    Traded Apr 17 Filed Apr 21
  26. Wenbin Qiu CEO
    BZUNBaozun
    Buy
    $80K 28,500 shares at $2.79 +2.1% to stake
    Traded Apr 15–16 Filed Apr 17
  27. Wenbin Qiu CEO
    BZUNBaozun
    Buy
    $60K 23,600 shares at $2.55 +1.7% to stake
    Traded Apr 13–14 Filed Apr 15
  28. Junhua Wu Chief Strategy Officer
    BZUNBaozun
    Buy
    $40K 16,456 shares at $2.46 +14% to stake
    Traded Apr 10–13 Filed Apr 14
  29. Wenbin Qiu CEO
    BZUNBaozun
    Buy
    $60K 24,050 shares at $2.50 +1.8% to stake
    Traded Apr 9–10 Filed Apr 13
  30. Junhua Wu Chief Strategy Officer
    BZUNBaozun
    Buy
    $78K 30,886 shares at $2.54 +34% to stake
    Traded Apr 8 Filed Apr 10
  31. Wenbin Qiu CEO
    BZUNBaozun
    Buy
    $60K 23,600 shares at $2.54 +1.8% to stake
    Traded Apr 7–8 Filed Apr 9
  32. Junhua Wu Chief Strategy Officer
    BZUNBaozun
    Buy
    $74K 30,000 shares at $2.47 +49% to stake
    Traded Apr 2 Filed Apr 6
  33. Junhua Wu Chief Strategy Officer
    BZUNBaozun
    Buy
    $34K 14,000 shares at $2.40 +30% to stake
    Traded Mar 31 Filed Apr 1

About this data

  • Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
  • Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
  • A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
  • Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
  • We cover the 4,841 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.